@article{garay:inserm-02272394,
  TITLE = {{Cost‑Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV‑1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM)}},
  AUTHOR = {Garay, Osvaldo Ulises and Nishimwe, Marie Lib{\'e}r{\'e}e and Bousmah, Marw{\^a}n-Al-Qays and Janah, Asmaa and Girard, Pierre-Marie and Chene, Genevi{\`e}ve and Moinot, Laetitia and Sagaon-Teyssier, Luis and Meynard, Jean-Luc and Spire, Bruno and Boyer, Sylvie},
  URL = {https://inserm.hal.science/inserm-02272394},
  JOURNAL = {{PharmacoEconomics - Open}},
  PUBLISHER = {{[Cham, Switzerland] : Springer International Publishing AG, [2017]-}},
  PAGES = {Epub ahead of print},
  YEAR = {2019},
  MONTH = Apr,
  DOI = {10.1007/s41669-019-0130-7},
  PDF = {https://inserm.hal.science/inserm-02272394v1/file/Garay2019_Article_Cost-EffectivenessAnalysisOfLo.pdf},
  HAL_ID = {inserm-02272394},
  HAL_VERSION = {v1},
}